News
Fatty liver expert: ‘We face a moral, ethical and medical imperative’
www.healio.com
SAN FRANCISCO — Beyond finding a “cure” to nonalcoholic fatty liver disease, one expert at The Liver Meeting called on physicians and...
Gilead Sciences Teams with TARGET PharmaSolutions on Liver Studies |...
www.ncbiotech.org
Chapel Hill-based TARGET PharmaSolutions, a clinical data company focused on real-world evidence in disease studies, has formed a strategic partnership with...
sortiert nach Relevanz / Datum